ATRO · Astronics Corp
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
The closing range begins at the captured split on Jun 15, 2026.
Up next
Latest documents
Astronics Corporation reported third quarter sales of $271.7 million, up 28.5%, with adjusted EBITDA margin of 21.8%. It maintained 2026 revenue guidance of $1.02 billion to $1.04 billion and expects 2027 growth well north of 10%.
Astronics Corporation reported record third-quarter 2026 sales of $271.7 million, up 28.5%, operating income of $54.0 million and net income of $52.2 million. Backlog reached $780.0 million, while 2026 revenue guidance remained $1.02 billion to $1.04 billion.
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Nov 10, 2026TL;DR. Astronics delivered record sales and operating income, broad-based Aerospace growth with record backlog, Test Systems improvement, $25.8 million of operating cash flow, debt reduction, lower planned capital expenditures, maintained 2026 guidance, and preliminary 2027 expectations well north of 10% growth. Risks include MV75 replanning, weaker Test Systems quarterly bookings, fourth-quarter margin and R&D pressure, supply-chain constraints, softer fourth-quarter revenue, and macroeconomic and oil-price headwinds.
- + Reported third-quarter results benefited from approximately $4.4 million of UK patent-related recoveries and an approximately $1 million favorable settlement.
- − The MV75 program is being rescheduled and replanned after previously operating on an accelerated schedule.
- − Test Systems quarterly bookings were $12.8 million, producing a 0.49:1 book-to-bill ratio, although trailing-twelve-month bookings were $121.8 million at 1.41:1.
- − Fourth-quarter margin will depend on sales mix, and R&D expense is expected to increase because of project timing.
- − Supply-chain lead times are stretching and price escalation is being observed in some components.
- − Fourth-quarter revenue is expected to step back modestly from the record third quarter despite a wide $255 million to $275 million guidance range.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Operating Margin | 20.3% | the three months ended July 4, 2026 filing | — |
| Test Systems segment operating margin | 2.6% | Three Months Ended July 4, 2026 filing | — |
| Adjusted Aerospace operating margin non-GAAP | 21.4% | Q2 2026 | — |
| Adjusted EBITDA non-GAAP | $51.5M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income $35.06M
+$2.33M Interest expense
+$2.79M Income tax expense
+$6.34M Depreciation and amortization expense
+$2.26M Equity-based compensation expense
+$0K Simplification and restructuring initiatives
+$482K ERP implementation consulting expenses
+$0K Legal reserve, settlements and recoveries
+$1.87M Litigation-related legal expenses
+$0K Acquisition-related expenses
+$406K Warranty reserve
= Adjusted EBITDA $51.55M
|
|||
| Adjusted EBITDA margin non-GAAP | 19.8% | Q2 2026 | — |
| Adjusted gross margin non-GAAP | 33.6% | Q2 2026 | — |
| Adjusted operating margin non-GAAP | 16.6% | Q2 2026 | — |
| Adjusted Test Systems margin non-GAAP | 3.1% | Q2 2026 | — |
| Aerospace backlog | $657.2M | Q2 2026 | — |
| Aerospace Book-to-bill ratio | 1.02 | Q2 2026 | — |
| Aerospace bookings | $243.1M | Q2 2026 | — |
| Aerospace segment operating margin | 20.3% | Q2 2026 | — |
| Backlog | $780.6M | Q2 2026 | — |
| Book-to-bill ratio | 1.18 | Q2 2026 | — |
| Bookings | $306.2M | Q2 2026 | — |
| Test Systems backlog | $123.3M | Q2 2026 | — |
| Test Systems book-to-bill ratio | 2.78 | Q2 2026 | — |
| Test Systems Bookings | $63.05M | Q2 2026 | — |
| Test Systems segment bookings | $63.1M | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Aerospace & Defense — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATRO
this stock
Astronics Corp
|
$2.54B | — | +8.4% | — | 7.3% |
|
SPCX
Space Exploration Technologies Corp
|
$1.89T | — | — | — | 1.0% |
|
GE
General Electric Co
|
$342.88B | +7.7% | +18.5% | 38.3 | 1.2% |
|
RTX
RTX Corp
|
$267.97B | +8.3% | +17.1% | 32.2 | 1.0% |
|
EADSF
Airbus SE
|
$178.35B | -3.2% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATRO | +7.8% | -4.2% | -12.5% | -0.7% | +36.2% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +5.2% | -3.0% | -13.0% | -0.5% | +25.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.